Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.20.2
3. Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Computation of earnings per share

Diluted earnings per share, if presented, would include the dilution that would occur upon the exercise or conversion of all potentially dilutive securities into common stock using the “treasury stock” and/or “if converted” methods as applicable.

 

    Three Months Ended September 30     Six Months Ended September 30  
(In thousands, except per share data)   2020     2019     2020     2019  
Numerator:                        
Income (loss) from continuing operations   $ 151     $ (1,288 )   $ (557 )   $ (614 )
Income (loss) from discontinued operations     (31 )     85       917       126  
Net income   $ 120     $ (1,203 )   $ 360     $ (488 )
                                 
Denominator:                                
Weighted-average number of common shares outstanding: basic     2,008       1,317       1,924       1,317  
Dilutive effect of stock options     149       –       192       –  
Dilutive effect of restricted stock     2       –       2       –  
Weighted-average number of common shares outstanding: diluted     2,159       1,317       2,118       1,317  
                                 
Income (loss) per share from continuing operations   $ 0.07     $ (0.98 )   $ (0.26 )   $ (0.47 )
Income (loss) per share from discontinued operations     (0.01 )     0.06       0.43       0.10  
Net income per share: basic and diluted   $ 0.06     $ (0.92 )   $ 0.17     $ (0.37 )
Schedule of antidilutive shares

The computation of basic loss per share for the three and six months ended September 30, 2020 and 2019 excludes the potentially dilutive securities summarized in the table below because their inclusion would be anti-dilutive.

 

    Three Months Ended September 30,     Six Months Ended September 30  
(In thousands)   2020     2019     2020     2019  
Stock options     65       136       75       136  
Restricted stock     2       2       2       2  
Warrants     150       446       150       446  
Common stock units (1)     46       46       46       46  
      263       630       273       630  
Disaggregated Revenue by Source

The following table presents the Company’s disaggregated revenues by revenue source:

 

(In thousands)   Three Months Ended September 30,     Six Months Ended September 30  
Product   2020     2019     2020     2019  
Human Care   $ 4,776     $ 3,801     $ 10,094     $ 7,772  
Animal Care     951       912       1,388       1,325  
Other     42       14       54       124  
    $ 5,769     $ 4,727     $ 11,536     $ 9,221